174 related articles for article (PubMed ID: 11745446)
1. Induction of apoptosis in BCL-2-expressing rat prostate cancer cells using the Semliki Forest virus vector.
Murphy AM; Sheahan BJ; Atkins GJ
Int J Cancer; 2001 Nov; 94(4):572-8. PubMed ID: 11745446
[TBL] [Abstract][Full Text] [Related]
2. Inhibition of human lung carcinoma cell growth by apoptosis induction using Semliki Forest virus recombinant particles.
Murphy AM; Morris-Downes MM; Sheahan BJ; Atkins GJ
Gene Ther; 2000 Sep; 7(17):1477-82. PubMed ID: 11001367
[TBL] [Abstract][Full Text] [Related]
3. Novel vectors expressing anti-apoptotic protein Bcl-2 to study cell death in Semliki Forest virus-infected cells.
Kiiver K; Merits A; Sarand I
Virus Res; 2008 Jan; 131(1):54-64. PubMed ID: 17904678
[TBL] [Abstract][Full Text] [Related]
4. A novel neurotropic expression vector based on the avirulent A7(74) strain of Semliki Forest virus.
Vähä-Koskela MJ; Tuittila MT; Nygårdas PT; Nyman JK; Ehrengruber MU; Renggli M; Hinkkanen AE
J Neurovirol; 2003 Feb; 9(1):1-15. PubMed ID: 12587064
[TBL] [Abstract][Full Text] [Related]
5. A comparative study on the immunotherapeutic efficacy of recombinant Semliki Forest virus and adenovirus vector systems in a murine model for cervical cancer.
Riezebos-Brilman A; Walczak M; Regts J; Rots MG; Kamps G; Dontje B; Haisma HY; Wilschut J; Daemen T
Gene Ther; 2007 Dec; 14(24):1695-704. PubMed ID: 17928874
[TBL] [Abstract][Full Text] [Related]
6. Growth inhibitory effect of triple anti-tumor gene transfer using Semliki Forest virus vector in glioblastoma cells.
Lee JS; Lee JH; Poo H; Kim MS; Lee SH; Sung MH; Kim CJ
Int J Oncol; 2006 Mar; 28(3):649-54. PubMed ID: 16465369
[TBL] [Abstract][Full Text] [Related]
7. Treatment of rapidly growing K-BALB and CT26 mouse tumours using Semliki Forest virus and its derived vector.
Smyth JW; Fleeton MN; Sheahan BJ; Atkins GJ
Gene Ther; 2005 Jan; 12(2):147-59. PubMed ID: 15372069
[TBL] [Abstract][Full Text] [Related]
8. Expression of H5N1 influenza virus hemagglutinin protein fused with protein transduction domain in an alphavirus replicon system.
Yang SG; Wo JE; Li MW; Mi FF; Yu CB; Lv GL; Cao HC; Lu HF; Wang BH; Zhu H; Li LJ
J Virol Methods; 2010 Jan; 163(1):31-9. PubMed ID: 19646478
[TBL] [Abstract][Full Text] [Related]
9. Vesicular stomatitis virus glycoprotein: a transducing coat for SFV-based RNA vectors.
Dorange F; Piver E; Bru T; Collin C; Roingeard P; Pagès JC
J Gene Med; 2004 Sep; 6(9):1014-22. PubMed ID: 15352074
[TBL] [Abstract][Full Text] [Related]
10. Novel Semliki Forest virus vectors with reduced cytotoxicity and temperature sensitivity for long-term enhancement of transgene expression.
Lundstrom K; Abenavoli A; Malgaroli A; Ehrengruber MU
Mol Ther; 2003 Feb; 7(2):202-9. PubMed ID: 12597908
[TBL] [Abstract][Full Text] [Related]
11. Efficient gene delivery into mammalian cells by recombinant baculovirus containing a hybrid cytomegalovirus promoter/Semliki Forest virus replicon.
Pan Y; Zhao Q; Fang L; Luo R; Chen H; Xiao S
J Gene Med; 2009 Nov; 11(11):1030-8. PubMed ID: 19757479
[TBL] [Abstract][Full Text] [Related]
12. Prostate-specific expression of Bax delivered by an adenoviral vector induces apoptosis in LNCaP prostate cancer cells.
Lowe SL; Rubinchik S; Honda T; McDonnell TJ; Dong JY; Norris JS
Gene Ther; 2001 Sep; 8(18):1363-71. PubMed ID: 11571575
[TBL] [Abstract][Full Text] [Related]
13. Functional applications of novel Semliki Forest virus vectors are limited by vector toxicity in cultures of primary neurons in vitro and in the substantia nigra in vivo.
Lingor P; Schöll U; Bähr M; Kügler S
Exp Brain Res; 2005 Mar; 161(3):335-42. PubMed ID: 15502982
[TBL] [Abstract][Full Text] [Related]
14. Inhibition of angiogenesis by a Semliki Forest virus vector expressing VEGFR-2 reduces tumour growth and metastasis in mice.
Lyons JA; Sheahan BJ; Galbraith SE; Mehra R; Atkins GJ; Fleeton MN
Gene Ther; 2007 Mar; 14(6):503-13. PubMed ID: 17167497
[TBL] [Abstract][Full Text] [Related]
15. Semliki Forest virus A7(74) transduces hippocampal neurons and glial cells in a temperature-dependent dual manner.
Ehrengruber MU; Renggli M; Raineteau O; Hennou S; Vähä-Koskela MJ; Hinkkanen AE; Lundstrom K
J Neurovirol; 2003 Feb; 9(1):16-28. PubMed ID: 12587065
[TBL] [Abstract][Full Text] [Related]
16. The Semliki Forest virus vector induces p53-independent apoptosis.
Glasgow GM; McGee MM; Tarbatt CJ; Mooney DA; Sheahan BJ; Atkins GJ
J Gen Virol; 1998 Oct; 79 ( Pt 10)():2405-10. PubMed ID: 9780045
[TBL] [Abstract][Full Text] [Related]
17. Molecular correlates of bcl-2-enhanced growth following androgen-ablation in prostate carcinoma cells in vivo.
Beham AW; Sarkiss M; Brisbay S; Tu SM; von Eschenbach AC; McDonnell TJ
Int J Mol Med; 1998 Jun; 1(6):953-9. PubMed ID: 9852630
[TBL] [Abstract][Full Text] [Related]
18. Novel mutant Semliki Forest virus vectors: gene expression and localization studies in neuronal cells.
Lundstrom K; Rotmann D; Hermann D; Schneider EM; Ehrengruber MU
Histochem Cell Biol; 2001 Jan; 115(1):83-91. PubMed ID: 11219612
[TBL] [Abstract][Full Text] [Related]
19. A Semliki forest virus vector engineered to express IFNα induces efficient elimination of established tumors.
Quetglas JI; Fioravanti J; Ardaiz N; Medina-Echeverz J; Baraibar I; Prieto J; Smerdou C; Berraondo P
Gene Ther; 2012 Mar; 19(3):271-8. PubMed ID: 21734727
[TBL] [Abstract][Full Text] [Related]
20. Part I. Bcl-2 and Bcl-x(L) limit apoptosis upon infection with alphavirus vectors.
Mastrangelo AJ; Hardwick JM; Bex F; Betenbaugh MJ
Biotechnol Bioeng; 2000 Mar; 67(5):544-54. PubMed ID: 10649229
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
